Rising Costs of Oral Anticancer Drugs Burden Medicare Recipients; New Law May Provide Some Relief
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Hematologic Cancers
Pemazyre Approved for Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
The approval was based on data from the phase 2 FIGHT-203 study, which included 28 patients with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Approved Anticancer Drugs Provide “Marginal” Improvements in Survival
Anticancer drugs approved by the FDA in the last 2 decades provide modest improvements in survival, according to new research.
Illegitimate Online Pharmacies May Put Cancer Patients at Risk
Illegitimate online pharmacies are selling imatinib without a prescription, making false claims about being registered with regulatory bodies, and failing to provide patients with drug-related warnings.
Lack of Mask Mandates Leaves Cancer Patients Feeling Unprotected
Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.
Kymriah Gets Accelerated Approval for Relapsed/Refractory Follicular Lymphoma
The accelerated approval for Kymriah was based on data from the phase 2 ELARA trial.
Tibsovo Approval Expanded for Newly Diagnosed IDH1-Mutated AML
The approval was based on data from the phase 3 AGILE trial.
Gender Pay Gap Affects Most Medical Specialties, Persists Over Time
Women in academic medicine typically have lower starting salaries than men, and this disparity remains after 10 years on the job.
NCCN Advises Most Cancer Patients Receive 5 Doses of mRNA COVID-19 Vaccine
Most cancer patients should receive 3 primary doses of an mRNA COVID-19 vaccine and 2 booster doses, according to NCCN.
Study Reveals High Markup of Cancer Drug Prices and Failure to Disclose Prices Publicly
The median price markup was as high as 633.6% for 1 drug.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...